BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34992668)

  • 1. Effects of Qinghuang Powder on Acute Myeloid Leukemia Based on Network Pharmacology, Molecular Docking, and In Vitro Experiments.
    Zeng YJ; Wu M; Zhang H; Wu XP; Zhou L; Wan N; Wu ZH
    Evid Based Complement Alternat Med; 2021; 2021():6195174. PubMed ID: 34992668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation.
    Zeng YJ; Liu F; Wu M; Wu XP; Zhang DL; Yuan QQ; Zhou L; Wu ZH
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):219-230. PubMed ID: 36352148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the anti-aging mechanism of Si Jun Zi Tang by integrating network pharmacology and experimental validation
    Yuan Y; Zhang Y; Zheng R; Yuan H; Zhou R; Jia S; Liu J
    Aging (Albany NY); 2022 May; 14(9):3941-3955. PubMed ID: 35537009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic-Containing Qinghuang Powder () is an Alternative Treatment for Elderly Acute Myeloid Leukemia Patients Refusing Low-Intensity Chemotherapy.
    Fan T; Quan RC; Liu WY; Xiao HY; Tang XD; Liu C; Li L; Lv Y; Wang HZ; Xu YG; Guo XQ; Hu XM
    Chin J Integr Med; 2020 May; 26(5):339-344. PubMed ID: 31848890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia.
    Huang Z; Yang Y; Fan X; Ma W
    Front Pharmacol; 2022; 13():952677. PubMed ID: 36160389
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploring the mechanism of fraxetin against acute myeloid leukemia through cell experiments and network pharmacology.
    Fang T; Liu L; Liu W
    BMC Complement Med Ther; 2024 Jun; 24(1):226. PubMed ID: 38858650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking.
    Lee AY; Lee JY; Chun JM
    Plants (Basel); 2020 Dec; 9(12):. PubMed ID: 33321972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Arsenic-Containing Qinghuang Powder and Low-Intensity Chemotherapy in Elderly Patients with Acute Myeloid Leukemia.
    Wu YH; Xiao HY; Quan RC; Tang XD; Liu WY; Lyu Y; Chen Z; Liu C; Hu XM
    Chin J Integr Med; 2023 Sep; 29(9):832-837. PubMed ID: 37222831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Emodin in the Treatment of Bladder Cancer based on Network Pharmacology and Experimental Verification.
    Liu F; Li J; Zhou B; Shen Y; Tang J; Han J; Chen C; Shao K; Chen H; Yuan L
    Comb Chem High Throughput Screen; 2024 Mar; ():. PubMed ID: 38504574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol: Multi-Targets Mechanism on Neurodegenerative Diseases Based on Network Pharmacology.
    Wang W; Wang S; Liu T; Ma Y; Huang S; Lei L; Wen A; Ding Y
    Front Pharmacol; 2020; 11():694. PubMed ID: 32477148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.
    Ming J; Liu W; Wu H; Li Y; Yang E; Wang Z; Xiao H; Quan R; Hu X
    Biomed Pharmacother; 2021 Aug; 140():111767. PubMed ID: 34058439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Targets and Mechanisms of
    Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
    Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies.
    Taha KF; Khalil M; Abubakr MS; Shawky E
    J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Mechanism of Shen Huang Chong Ji for Treating Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
    Tang L; Liu J; Xu X; Zhao J; Han X
    Evid Based Complement Alternat Med; 2022; 2022():9243348. PubMed ID: 35656471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network Pharmacology-Based Investigation and Experimental Exploration of the Antiapoptotic Mechanism of Colchicine on Myocardial Ischemia Reperfusion Injury.
    Tang Y; Shi C; Qin Y; Wang S; Pan H; Chen M; Yu X; Lou Y; Fan G
    Front Pharmacol; 2021; 12():804030. PubMed ID: 34975499
    [No Abstract]   [Full Text] [Related]  

  • 19. Deciphering the Key Pharmacological Pathways and Targets of Yisui Qinghuang Powder That Acts on Myelodysplastic Syndromes Using a Network Pharmacology-Based Strategy.
    Han Z; Song L; Qi K; Ding Y; Wei M; Jia Y
    Evid Based Complement Alternat Med; 2020; 2020():8877295. PubMed ID: 33488754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology to Explore the Molecular Mechanisms of
    Gan XX; Zhong LK; Shen F; Feng JH; Li YY; Li SJ; Cai WS; Xu B
    Front Pharmacol; 2021; 12():700896. PubMed ID: 34690752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.